Summary of opinion: Enhertu, 23/07/2026 Positive
Submitted by Anonymous (not verified) on 24 July 2026 - 11:00
Summary of opinion: Enhertu, 23/07/2026 Positive
Human medicines European public assessment report (EPAR): Nezglyal, leriglitazone, Status: Opinion
Submitted by Anonymous (not verified) on 24 July 2026 - 11:00
Human medicines European public assessment report (EPAR): Nezglyal, leriglitazone, Status: Opinion
Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 61, Status: Authorised
Submitted by Anonymous (not verified) on 24 July 2026 - 10:42
Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 61, Status: Authorised
Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine, Date of authorisation: 21/12/2020, Revision: 62, Status: Authorised
Submitted by Anonymous (not verified) on 24 July 2026 - 10:37
Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine, Date of authorisation: 21/12/2020, Revision: 62, Status: Authorised
Minutes - HMA-EMA joint Network Data Steering Group meeting - 16 June 2026
Submitted by Anonymous (not verified) on 24 July 2026 - 9:37
Minutes - HMA-EMA joint Network Data Steering Group meeting - 16 June 2026
Cardiac valves - Notified Body 0344 - 20/12/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)
Submitted by Anonymous (not verified) on 24 July 2026 - 9:30
Cardiac valves - Notified Body 0344 - 20/12/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)
Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2026
Submitted by Anonymous (not verified) on 24 July 2026 - 9:30
Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2026
Minutes – Ad hoc Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 12 June 2026
Submitted by Anonymous (not verified) on 24 July 2026 - 9:05
Minutes – Ad hoc Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 12 June 2026
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – June 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 June 2026, 16:30 (CEST) to 12 June 2026, 17:30 (CEST)
Submitted by Anonymous (not verified) on 24 July 2026 - 9:00
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – June 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 June 2026, 16:30 (CEST) to 12 June 2026, 17:30 (CEST)
Concept paper on the revision of the guideline on pharmaceutical fixed combination products (EMA/CVMP/83804/2005-Rev.1)
Submitted by Anonymous (not verified) on 24 July 2026 - 8:06
Concept paper on the revision of the guideline on pharmaceutical fixed combination products (EMA/CVMP/83804/2005-Rev.1)